US Grants.gov · Ouvert

Reissue of RFA-FD-23-001- Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01 Clinical Trials Required)

Page officielle de l'appel ↗

In brief, in English

This funding opportunity supports clinical trials evaluating the efficacy and safety of products to support new indications or label changes addressing unmet needs in rare diseases. The text does not specify eligible applicant types.

Written by a model from the publisher's text. The official page is the authority. How data is produced

The purpose of this Notice of Funding Opportunity (NOFO) is to fund clinical trials of products evaluating efficacy and/or safety in support of a new indication or change in labeling to address unmet needs in rare diseases or conditions. Additionally, through the funding of collaborative, efficient, and/or innovative clinical trials, FDA expects to increase the number of approved treatments for rare diseases and exert a broad and positive impact on rare disease drug development.

Historique des changements

First seen 28 Sept 2026, last checked 22 Nov 2026. 1 recorded version.

  • 28 Sept 2026 · 7114a7f4322d

Report a problem with this record · How data is produced